|
Pc | Concentration | Target microbes | Efficacy reduction | Inhibition zone/% reduction | Ref. |
|
Zinc-tetra(4-carboxyphenyl)Pc | 39.5 μg/mL | Escherichia coli | | 100.00% | [19] |
Zinc-tetra(4-carboxyphenyl)Pc | 22.02 μg/L | Enterococcus faecalis | | 32.91% | [19] |
Zinc-tetra(4-carboxyphenyl)Pc | 10.43 μg/mL | Klebsiella pneumonia | | 100.00% | [19] |
Zinc-tetra(4-carboxyphenyl)Pc | 22.48 μg/mL | Pseudomonas aeruginosa | | 12.25% | [19] |
Zinc-tetra(4-carboxyphenyl)Pc | 16.03 μg/Ml | Staphylococcus aureus | | 72.22% | [19] |
Cobalt 2, 9, 16, 23-tetra-phenyliminophthalocyanine | 500 ppm | Xanthomonas campestris | | 16 mm | [20] |
Xanthomonas citri | 17 mm |
Copper 2, 9, 16, 23-tetra-phenyliminophthalocyanine | 500 ppm | Xanthomonas campestris | | 19 mm | [20] |
Xanthomonas citri | | 19 mm |
Nickel 2, 9, 16, 23-tetra-phenyliminophthalocyanine | 500 ppm | Xanthomonas campestris | | 18 mm | [20] |
Xanthomonas citri | | 18 mm |
Zinc 2, 9, 16, 23-tetra-phenyliminophthalocyanine | 500 ppm | Xanthomonas campestris | | 19 mm | [20] |
Xanthomonas citri | | 19 mm |
Zinc phthalocyanine(neutral) | 2 mM | Aeromonas hydrophila | <0.5 log | | [21] |
Tetra zinc (II)phthalocyanine | 64 ng/mL | Staphylococcus aureus | 5-6 logs | | [21] |
Cationic zinc(II)phthalocyanine substituted with triamino | 13 nM | Staphylococcus aureus | 4 logs | | [21] |
Neutral uncharged Zn(II)pyridyloxyphthalocyanine | 10 µM | Escherichia coli | 0.5 logs | | [21] |
Chromium (III) phthalocyanine chloride complex | | Escherichia coli | | 12 mm | [22] |
Chromium (III) phthalocyanine chloride complex | | Pseudomonas aeruginosa | | 9 mm | [22] |
Chromium (III) phthalocyanine chloride complex | | Staphylococcus aureus | | 10 mm | [22] |
Chromium (III) phthalocyanine chloride complex | | Bacillus cereus | | 11 mm | [22] |
2,9,16,23-Tetra-N-[4-(5-phenyl-1,3,4-oxadiazol-2-yl)phenyl]benzamido-nickelphthalocyanines | 40 μg/mL | Staphylococcus aureus | | 23 mm | [23] |
Pseudomonas aeruginosa | | 27 mm |
Klebsiella pneumonia | | 28 mm |
2,9,16,23-Tetra-N-[4-(5-phenyl-1,3,4-oxadiazol-2-yl)phenyl]benzamido-cobalt phthalocyanine | 40 μg/mL | Staphylococcus aureus | | 25 mm | [23] |
Pseudomonas aeruginosa | | 26 mm |
Klebsiella pneumoniae | | 29 mm |
2,9,16,23-Tetra-N-[4-(5-phenyl-1,3,4-oxadiazol-2-yl)phenyl]benzamido-cobalt phthalocyanine | 40 μg/mL | Staphylococcus aureus | | 26 mm | [23] |
Pseudomonas aeruginosa | | 27 mm |
Klebsiella pneumoniae | | 28 mm |
Zinc phthalocyanine with sulphamidic substituents | 50 mg/100 ml | Pseudomonas aeruginosa | 6 log | | [24] |
Escherichia coli | 4 log |
Enterococcus faecalis | <0.5 log |
Tris,19,27-(1,2-diethylaminoethylthiol)-2-(captopril) phthalocyanines Zn | 20 uM | Escherichia coli | | 90% | [16] |
Tris,19,27-(1,2-diethylaminoethylthiol)-2-(captopril) phthalocyanines Zn conjugated to silver nanoparticles | 20 uM | Escherichia coli | | 95% | [16] |
|